Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

MGI

Nil


Contact Details:
610 Main Street
Bar Harbor
Maine
04609
United States of America
Tel:
Fax:207-288-6106
Email:jobs@jax.org
WWW:

www.informatics.jax.org/




Loading...

Recent Publications by MGI:

Searching the Mouse Genome Informatics (MGI) resources for information on mouse biology from genotype to phenotype.
The Mouse Genome Informatics (MGI) resource provides the research...
9th May, 2009
MGI User Support, The Jackson Laboratory, Bar Harbor, Maine. Curr Protoc Bioinformatics. 2009 Mar;Chapter 1:Unit1.7.
DOI Direct Link
[Bariatric surgery in Denmark--are we on the right way?]
INTRODUCTION: In 2005 the National Board of Health (NBH) published...
23rd January, 2009
Sundhedsstyrelsen, Monitorering og Medicinsk Teknologivurdering, Islands Ugeskr Laeger. 2008 Dec 8;170(50):4128-30.
Targeting cytochrome P450 CYP1B1 with a therapeutic cancer vaccine.
The role that the immune system plays in limiting tumor formation and...
24th October, 2008
MGI Pharma, 35 Hartwell Avenue, Lexington, MA 02421, USA. Expert Rev Vaccines. 2008 Sep;7(7):995-1003.
DOI Direct Link
Synthesis and biological evaluation of D-amino acid oxidase inhibitors.
D-amino acid oxidase (DAAO) catalyzes the oxidation of D-amino acids...
6th September, 2008
MGI Pharma, Inc. J Med Chem. 2008 Jun 26;51(12):3357-9. Epub 2008 May 29.
DOI Direct Link
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.
BACKGROUND: Palonosetron is a 5-HT(3)-receptor antagonist (5-HT(3)-RA)...
30th August, 2008
Research and Translational Development, MGI PHARMA INC, 6611 Tributary Anesth Analg. 2008 Aug;107(2):469-78.
DOI Direct Link

View more MGI research publications.

Press Releases on MGI:

BioPortfolio Logo
Reportlinker Adds Alzheimer's and Parkinson's Diseases - A Global Update of Market Trends & Opportunities 18th November, 2009 Reportlinker
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Alzheimer's and Parkinson's Diseases - A Global Update of Market
Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 11th November, 2009 Access Pharmaceuticals, Inc.
-- Co-Promotion: Access continues to seek potential co-promotion arrangements with pharmaceutical and biotechnology companies in the oncology and oncology supportive care fields.
New Report Just Published: World Prostate Cancer Therapeutics Market Report 7th July, 2009 Reportlinker
NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Prostate Cancer Therapeutics Market http://www.reportlinker.com/p0119471/World
Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting 1st June, 2009 bioTheranostics
- THEROS CancerTYPE ID(R) predicts cancer origin with 75 percent accuracy in patients whose primary cancer was 'unknown' using traditional diagnostics - SAN DIEGO, June 1 /PRNewswire/ --
Call for Nominations for the 2009 C.A.R.E. Pharmacy Award 1st June, 2009 Eisai Inc.
Eisai Inc. and the Alzheimer's Association Support Award to Recognize Critical Role of Pharmacists in Alzheimer's Care WOODCLIFF LAKE, N.J., June 1 /PRNewswire/ -- Eisai Inc., in

BioNews Results for MGI:

Access Pharmaceuticals (ACCP) Provides Update on MuGard Commercial Launch in North America
BioSpace:  Nov 11 2009 7:44PM Matching: mgi
Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America
Therapeutics Daily:  Nov 11 2009 6:21PM Matching: mgi
Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America European Launch Ongoing -- Initial Clinician And Patient Feedback
Yahoo! Canada:  Nov 11 2009 3:10PM Matching: mgi
Jov Diversified Flow-Through 2009 Limited Partnership: Books Closing Nov. 4, 2009 @ 12 Noon EST
Genetic Engineering News:  Nov 4 2009 1:34AM Matching: mgi
SuperGen Reports 2009 Third Quarter Financial Results
Pharmacy Choice:  Oct 27 2009 3:32AM Matching: mgi
Promote your company here: BioNewsCast - Press Release Distribution

View more MGI news.

MGI Patents:

US Patent No.Title
7456178 Compounds, methods and pharmaceutical compositions for inhibiting PARP
6300955 Method and system for mask generation
6285410 Method and system for removal of flash artifacts from digital images
6246413 Method and system for creating panoramas
6239807 Method and system for multi-resolution texture mapping

View more MGI patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 261 times since April 2007, the link to the organisation's website has been followed 52 times

Recent Search Terms used to find this page: lusedra synthesis | .

Search for more companies in Bar Harbor

Search for more companies in Maine



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for MGI

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.